nodes	percent_of_prediction	percent_of_DWPC	metapath
Donepezil—CYP3A4—Thiotepa—urinary bladder cancer	0.0491	0.36	CbGbCtD
Donepezil—CYP2C9—Fluorouracil—urinary bladder cancer	0.0274	0.201	CbGbCtD
Donepezil—CYP2C9—Cisplatin—urinary bladder cancer	0.0233	0.171	CbGbCtD
Donepezil—CYP2D6—Doxorubicin—urinary bladder cancer	0.0143	0.105	CbGbCtD
Donepezil—CYP3A4—Etoposide—urinary bladder cancer	0.0133	0.0975	CbGbCtD
Donepezil—CYP3A4—Doxorubicin—urinary bladder cancer	0.00908	0.0665	CbGbCtD
Donepezil—CYP2C9—urine—urinary bladder cancer	0.00827	0.118	CbGeAlD
Donepezil—ACHE—prostate gland—urinary bladder cancer	0.00684	0.0977	CbGeAlD
Donepezil—HTR2A—urine—urinary bladder cancer	0.00681	0.0973	CbGeAlD
Donepezil—CYP3A4—urine—urinary bladder cancer	0.00631	0.0901	CbGeAlD
Donepezil—CYP2D6—urine—urinary bladder cancer	0.0062	0.0886	CbGeAlD
Donepezil—SIGMAR1—prostate gland—urinary bladder cancer	0.00459	0.0655	CbGeAlD
Donepezil—SIGMAR1—seminal vesicle—urinary bladder cancer	0.00388	0.0554	CbGeAlD
Donepezil—SIGMAR1—smooth muscle tissue—urinary bladder cancer	0.00325	0.0464	CbGeAlD
Donepezil—SIGMAR1—urethra—urinary bladder cancer	0.00307	0.0439	CbGeAlD
Donepezil—SIGMAR1—vagina—urinary bladder cancer	0.00227	0.0324	CbGeAlD
Donepezil—ACHE—lymph node—urinary bladder cancer	0.00218	0.0312	CbGeAlD
Donepezil—HTR2A—epithelium—urinary bladder cancer	0.0018	0.0257	CbGeAlD
Donepezil—HTR2A—smooth muscle tissue—urinary bladder cancer	0.00173	0.0247	CbGeAlD
Donepezil—HTR2A—renal system—urinary bladder cancer	0.00167	0.0238	CbGeAlD
Donepezil—CYP2C9—female reproductive system—urinary bladder cancer	0.00162	0.0231	CbGeAlD
Donepezil—CYP3A4—renal system—urinary bladder cancer	0.00154	0.022	CbGeAlD
Donepezil—CYP2D6—renal system—urinary bladder cancer	0.00152	0.0217	CbGeAlD
Donepezil—SIGMAR1—lymph node—urinary bladder cancer	0.00147	0.0209	CbGeAlD
Donepezil—HTR2A—female reproductive system—urinary bladder cancer	0.00133	0.0191	CbGeAlD
Donepezil—CYP3A4—female reproductive system—urinary bladder cancer	0.00124	0.0176	CbGeAlD
Donepezil—CYP2D6—female reproductive system—urinary bladder cancer	0.00122	0.0174	CbGeAlD
Donepezil—HTR2A—vagina—urinary bladder cancer	0.00121	0.0172	CbGeAlD
Donepezil—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000364	0.000504	CcSEcCtD
Donepezil—Pneumonia—Doxorubicin—urinary bladder cancer	0.000362	0.000501	CcSEcCtD
Donepezil—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000362	0.000501	CcSEcCtD
Donepezil—Pruritus—Fluorouracil—urinary bladder cancer	0.000361	0.000499	CcSEcCtD
Donepezil—Infestation—Doxorubicin—urinary bladder cancer	0.00036	0.000498	CcSEcCtD
Donepezil—Infestation NOS—Doxorubicin—urinary bladder cancer	0.00036	0.000498	CcSEcCtD
Donepezil—Visual impairment—Methotrexate—urinary bladder cancer	0.00036	0.000498	CcSEcCtD
Donepezil—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000356	0.000493	CcSEcCtD
Donepezil—Bradycardia—Epirubicin—urinary bladder cancer	0.000355	0.000492	CcSEcCtD
Donepezil—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000355	0.000491	CcSEcCtD
Donepezil—Renal failure—Doxorubicin—urinary bladder cancer	0.000354	0.00049	CcSEcCtD
Donepezil—Urticaria—Etoposide—urinary bladder cancer	0.000352	0.000487	CcSEcCtD
Donepezil—Haemoglobin—Epirubicin—urinary bladder cancer	0.000351	0.000486	CcSEcCtD
Donepezil—Jaundice—Doxorubicin—urinary bladder cancer	0.000351	0.000486	CcSEcCtD
Donepezil—Rhinitis—Epirubicin—urinary bladder cancer	0.00035	0.000485	CcSEcCtD
Donepezil—Abdominal pain—Etoposide—urinary bladder cancer	0.00035	0.000484	CcSEcCtD
Donepezil—Body temperature increased—Etoposide—urinary bladder cancer	0.00035	0.000484	CcSEcCtD
Donepezil—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.00035	0.000484	CcSEcCtD
Donepezil—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.00035	0.000484	CcSEcCtD
Donepezil—Haemorrhage—Epirubicin—urinary bladder cancer	0.000349	0.000483	CcSEcCtD
Donepezil—Hepatitis—Epirubicin—urinary bladder cancer	0.000349	0.000483	CcSEcCtD
Donepezil—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000349	0.000483	CcSEcCtD
Donepezil—Tinnitus—Methotrexate—urinary bladder cancer	0.000348	0.000482	CcSEcCtD
Donepezil—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000347	0.000481	CcSEcCtD
Donepezil—Asthenia—Cisplatin—urinary bladder cancer	0.000347	0.00048	CcSEcCtD
Donepezil—Pharyngitis—Epirubicin—urinary bladder cancer	0.000347	0.00048	CcSEcCtD
Donepezil—Sweating—Doxorubicin—urinary bladder cancer	0.000345	0.000478	CcSEcCtD
Donepezil—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000345	0.000477	CcSEcCtD
Donepezil—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000344	0.000476	CcSEcCtD
Donepezil—Haematuria—Doxorubicin—urinary bladder cancer	0.000343	0.000475	CcSEcCtD
Donepezil—Urethral disorder—Epirubicin—urinary bladder cancer	0.000342	0.000474	CcSEcCtD
Donepezil—Epistaxis—Doxorubicin—urinary bladder cancer	0.000339	0.00047	CcSEcCtD
Donepezil—Dizziness—Fluorouracil—urinary bladder cancer	0.000337	0.000466	CcSEcCtD
Donepezil—Visual impairment—Epirubicin—urinary bladder cancer	0.000336	0.000466	CcSEcCtD
Donepezil—Chills—Methotrexate—urinary bladder cancer	0.000335	0.000463	CcSEcCtD
Donepezil—Diarrhoea—Cisplatin—urinary bladder cancer	0.000331	0.000458	CcSEcCtD
Donepezil—Alopecia—Methotrexate—urinary bladder cancer	0.00033	0.000456	CcSEcCtD
Donepezil—Vomiting—Gemcitabine—urinary bladder cancer	0.00033	0.000456	CcSEcCtD
Donepezil—Bradycardia—Doxorubicin—urinary bladder cancer	0.000329	0.000455	CcSEcCtD
Donepezil—Mental disorder—Methotrexate—urinary bladder cancer	0.000327	0.000453	CcSEcCtD
Donepezil—Rash—Gemcitabine—urinary bladder cancer	0.000327	0.000452	CcSEcCtD
Donepezil—Dermatitis—Gemcitabine—urinary bladder cancer	0.000326	0.000452	CcSEcCtD
Donepezil—Hypersensitivity—Etoposide—urinary bladder cancer	0.000326	0.000451	CcSEcCtD
Donepezil—Tinnitus—Epirubicin—urinary bladder cancer	0.000326	0.000451	CcSEcCtD
Donepezil—Erythema—Methotrexate—urinary bladder cancer	0.000325	0.00045	CcSEcCtD
Donepezil—Malnutrition—Methotrexate—urinary bladder cancer	0.000325	0.00045	CcSEcCtD
Donepezil—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000325	0.00045	CcSEcCtD
Donepezil—Headache—Gemcitabine—urinary bladder cancer	0.000325	0.000449	CcSEcCtD
Donepezil—Vomiting—Fluorouracil—urinary bladder cancer	0.000324	0.000449	CcSEcCtD
Donepezil—Rhinitis—Doxorubicin—urinary bladder cancer	0.000324	0.000448	CcSEcCtD
Donepezil—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000323	0.000447	CcSEcCtD
Donepezil—Hepatitis—Doxorubicin—urinary bladder cancer	0.000323	0.000447	CcSEcCtD
Donepezil—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000321	0.000445	CcSEcCtD
Donepezil—Rash—Fluorouracil—urinary bladder cancer	0.000321	0.000445	CcSEcCtD
Donepezil—Dermatitis—Fluorouracil—urinary bladder cancer	0.000321	0.000444	CcSEcCtD
Donepezil—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000321	0.000444	CcSEcCtD
Donepezil—Headache—Fluorouracil—urinary bladder cancer	0.000319	0.000442	CcSEcCtD
Donepezil—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000319	0.000442	CcSEcCtD
Donepezil—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000318	0.000441	CcSEcCtD
Donepezil—Dysgeusia—Methotrexate—urinary bladder cancer	0.000318	0.00044	CcSEcCtD
Donepezil—Asthenia—Etoposide—urinary bladder cancer	0.000318	0.00044	CcSEcCtD
Donepezil—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000317	0.000438	CcSEcCtD
Donepezil—Back pain—Methotrexate—urinary bladder cancer	0.000314	0.000435	CcSEcCtD
Donepezil—Chills—Epirubicin—urinary bladder cancer	0.000313	0.000434	CcSEcCtD
Donepezil—Pruritus—Etoposide—urinary bladder cancer	0.000313	0.000433	CcSEcCtD
Donepezil—Arrhythmia—Epirubicin—urinary bladder cancer	0.000312	0.000432	CcSEcCtD
Donepezil—Visual impairment—Doxorubicin—urinary bladder cancer	0.000311	0.000431	CcSEcCtD
Donepezil—Alopecia—Epirubicin—urinary bladder cancer	0.000309	0.000427	CcSEcCtD
Donepezil—Nausea—Gemcitabine—urinary bladder cancer	0.000308	0.000426	CcSEcCtD
Donepezil—Vomiting—Cisplatin—urinary bladder cancer	0.000307	0.000425	CcSEcCtD
Donepezil—Vision blurred—Methotrexate—urinary bladder cancer	0.000306	0.000424	CcSEcCtD
Donepezil—Mental disorder—Epirubicin—urinary bladder cancer	0.000306	0.000423	CcSEcCtD
Donepezil—Rash—Cisplatin—urinary bladder cancer	0.000305	0.000422	CcSEcCtD
Donepezil—Dermatitis—Cisplatin—urinary bladder cancer	0.000304	0.000421	CcSEcCtD
Donepezil—Erythema—Epirubicin—urinary bladder cancer	0.000304	0.000421	CcSEcCtD
Donepezil—Malnutrition—Epirubicin—urinary bladder cancer	0.000304	0.000421	CcSEcCtD
Donepezil—Diarrhoea—Etoposide—urinary bladder cancer	0.000303	0.000419	CcSEcCtD
Donepezil—Nausea—Fluorouracil—urinary bladder cancer	0.000303	0.000419	CcSEcCtD
Donepezil—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000301	0.000417	CcSEcCtD
Donepezil—Tinnitus—Doxorubicin—urinary bladder cancer	0.000301	0.000417	CcSEcCtD
Donepezil—Anaemia—Methotrexate—urinary bladder cancer	0.0003	0.000416	CcSEcCtD
Donepezil—Flatulence—Epirubicin—urinary bladder cancer	0.0003	0.000415	CcSEcCtD
Donepezil—Tension—Epirubicin—urinary bladder cancer	0.000298	0.000413	CcSEcCtD
Donepezil—Dysgeusia—Epirubicin—urinary bladder cancer	0.000298	0.000412	CcSEcCtD
Donepezil—Nervousness—Epirubicin—urinary bladder cancer	0.000295	0.000409	CcSEcCtD
Donepezil—Back pain—Epirubicin—urinary bladder cancer	0.000294	0.000407	CcSEcCtD
Donepezil—Malaise—Methotrexate—urinary bladder cancer	0.000293	0.000405	CcSEcCtD
Donepezil—Dizziness—Etoposide—urinary bladder cancer	0.000293	0.000405	CcSEcCtD
Donepezil—Muscle spasms—Epirubicin—urinary bladder cancer	0.000292	0.000405	CcSEcCtD
Donepezil—Vertigo—Methotrexate—urinary bladder cancer	0.000292	0.000404	CcSEcCtD
Donepezil—Chills—Doxorubicin—urinary bladder cancer	0.00029	0.000401	CcSEcCtD
Donepezil—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000289	0.0004	CcSEcCtD
Donepezil—Nausea—Cisplatin—urinary bladder cancer	0.000287	0.000397	CcSEcCtD
Donepezil—Vision blurred—Epirubicin—urinary bladder cancer	0.000286	0.000397	CcSEcCtD
Donepezil—Alopecia—Doxorubicin—urinary bladder cancer	0.000285	0.000395	CcSEcCtD
Donepezil—Cough—Methotrexate—urinary bladder cancer	0.000283	0.000392	CcSEcCtD
Donepezil—Mental disorder—Doxorubicin—urinary bladder cancer	0.000283	0.000392	CcSEcCtD
Donepezil—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000282	0.00039	CcSEcCtD
Donepezil—Convulsion—Methotrexate—urinary bladder cancer	0.000281	0.00039	CcSEcCtD
Donepezil—Vomiting—Etoposide—urinary bladder cancer	0.000281	0.00039	CcSEcCtD
Donepezil—Malnutrition—Doxorubicin—urinary bladder cancer	0.000281	0.000389	CcSEcCtD
Donepezil—Erythema—Doxorubicin—urinary bladder cancer	0.000281	0.000389	CcSEcCtD
Donepezil—Anaemia—Epirubicin—urinary bladder cancer	0.000281	0.000389	CcSEcCtD
Donepezil—Agitation—Epirubicin—urinary bladder cancer	0.000279	0.000387	CcSEcCtD
Donepezil—Rash—Etoposide—urinary bladder cancer	0.000279	0.000386	CcSEcCtD
Donepezil—Dermatitis—Etoposide—urinary bladder cancer	0.000279	0.000386	CcSEcCtD
Donepezil—Headache—Etoposide—urinary bladder cancer	0.000277	0.000384	CcSEcCtD
Donepezil—Flatulence—Doxorubicin—urinary bladder cancer	0.000277	0.000384	CcSEcCtD
Donepezil—Chest pain—Methotrexate—urinary bladder cancer	0.000277	0.000383	CcSEcCtD
Donepezil—Arthralgia—Methotrexate—urinary bladder cancer	0.000277	0.000383	CcSEcCtD
Donepezil—Myalgia—Methotrexate—urinary bladder cancer	0.000277	0.000383	CcSEcCtD
Donepezil—Tension—Doxorubicin—urinary bladder cancer	0.000276	0.000382	CcSEcCtD
Donepezil—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000275	0.000381	CcSEcCtD
Donepezil—Malaise—Epirubicin—urinary bladder cancer	0.000274	0.000379	CcSEcCtD
Donepezil—Discomfort—Methotrexate—urinary bladder cancer	0.000273	0.000378	CcSEcCtD
Donepezil—Nervousness—Doxorubicin—urinary bladder cancer	0.000273	0.000378	CcSEcCtD
Donepezil—Vertigo—Epirubicin—urinary bladder cancer	0.000273	0.000378	CcSEcCtD
Donepezil—Syncope—Epirubicin—urinary bladder cancer	0.000273	0.000377	CcSEcCtD
Donepezil—Back pain—Doxorubicin—urinary bladder cancer	0.000272	0.000377	CcSEcCtD
Donepezil—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00027	0.000374	CcSEcCtD
Donepezil—Confusional state—Methotrexate—urinary bladder cancer	0.000267	0.00037	CcSEcCtD
Donepezil—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000267	0.00037	CcSEcCtD
Donepezil—Cough—Epirubicin—urinary bladder cancer	0.000265	0.000367	CcSEcCtD
Donepezil—Vision blurred—Doxorubicin—urinary bladder cancer	0.000265	0.000367	CcSEcCtD
Donepezil—Convulsion—Epirubicin—urinary bladder cancer	0.000263	0.000365	CcSEcCtD
Donepezil—Infection—Methotrexate—urinary bladder cancer	0.000263	0.000365	CcSEcCtD
Donepezil—Nausea—Etoposide—urinary bladder cancer	0.000263	0.000364	CcSEcCtD
Donepezil—Hypertension—Epirubicin—urinary bladder cancer	0.000262	0.000363	CcSEcCtD
Donepezil—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000261	0.000361	CcSEcCtD
Donepezil—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00026	0.00036	CcSEcCtD
Donepezil—Anaemia—Doxorubicin—urinary bladder cancer	0.00026	0.00036	CcSEcCtD
Donepezil—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00026	0.000359	CcSEcCtD
Donepezil—Arthralgia—Epirubicin—urinary bladder cancer	0.000259	0.000358	CcSEcCtD
Donepezil—Chest pain—Epirubicin—urinary bladder cancer	0.000259	0.000358	CcSEcCtD
Donepezil—Myalgia—Epirubicin—urinary bladder cancer	0.000259	0.000358	CcSEcCtD
Donepezil—Agitation—Doxorubicin—urinary bladder cancer	0.000258	0.000358	CcSEcCtD
Donepezil—Anxiety—Epirubicin—urinary bladder cancer	0.000258	0.000357	CcSEcCtD
Donepezil—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000256	0.000355	CcSEcCtD
Donepezil—Discomfort—Epirubicin—urinary bladder cancer	0.000256	0.000354	CcSEcCtD
Donepezil—Malaise—Doxorubicin—urinary bladder cancer	0.000254	0.000351	CcSEcCtD
Donepezil—Dry mouth—Epirubicin—urinary bladder cancer	0.000253	0.00035	CcSEcCtD
Donepezil—Vertigo—Doxorubicin—urinary bladder cancer	0.000253	0.00035	CcSEcCtD
Donepezil—Anorexia—Methotrexate—urinary bladder cancer	0.000253	0.00035	CcSEcCtD
Donepezil—Syncope—Doxorubicin—urinary bladder cancer	0.000252	0.000349	CcSEcCtD
Donepezil—Confusional state—Epirubicin—urinary bladder cancer	0.00025	0.000346	CcSEcCtD
Donepezil—Oedema—Epirubicin—urinary bladder cancer	0.000248	0.000343	CcSEcCtD
Donepezil—Hypotension—Methotrexate—urinary bladder cancer	0.000248	0.000343	CcSEcCtD
Donepezil—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000247	0.000342	CcSEcCtD
Donepezil—Infection—Epirubicin—urinary bladder cancer	0.000246	0.000341	CcSEcCtD
Donepezil—Cough—Doxorubicin—urinary bladder cancer	0.000245	0.00034	CcSEcCtD
Donepezil—Shock—Epirubicin—urinary bladder cancer	0.000244	0.000338	CcSEcCtD
Donepezil—Convulsion—Doxorubicin—urinary bladder cancer	0.000244	0.000337	CcSEcCtD
Donepezil—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000243	0.000337	CcSEcCtD
Donepezil—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000243	0.000336	CcSEcCtD
Donepezil—Hypertension—Doxorubicin—urinary bladder cancer	0.000243	0.000336	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000241	0.000334	CcSEcCtD
Donepezil—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.00024	0.000332	CcSEcCtD
Donepezil—Insomnia—Methotrexate—urinary bladder cancer	0.00024	0.000332	CcSEcCtD
Donepezil—Arthralgia—Doxorubicin—urinary bladder cancer	0.000239	0.000331	CcSEcCtD
Donepezil—Chest pain—Doxorubicin—urinary bladder cancer	0.000239	0.000331	CcSEcCtD
Donepezil—Myalgia—Doxorubicin—urinary bladder cancer	0.000239	0.000331	CcSEcCtD
Donepezil—Anxiety—Doxorubicin—urinary bladder cancer	0.000239	0.00033	CcSEcCtD
Donepezil—Paraesthesia—Methotrexate—urinary bladder cancer	0.000238	0.00033	CcSEcCtD
Donepezil—Discomfort—Doxorubicin—urinary bladder cancer	0.000237	0.000328	CcSEcCtD
Donepezil—Anorexia—Epirubicin—urinary bladder cancer	0.000236	0.000327	CcSEcCtD
Donepezil—Dyspnoea—Methotrexate—urinary bladder cancer	0.000236	0.000327	CcSEcCtD
Donepezil—Somnolence—Methotrexate—urinary bladder cancer	0.000236	0.000326	CcSEcCtD
Donepezil—Dry mouth—Doxorubicin—urinary bladder cancer	0.000234	0.000324	CcSEcCtD
Donepezil—Dyspepsia—Methotrexate—urinary bladder cancer	0.000233	0.000323	CcSEcCtD
Donepezil—Hypotension—Epirubicin—urinary bladder cancer	0.000232	0.000321	CcSEcCtD
Donepezil—Confusional state—Doxorubicin—urinary bladder cancer	0.000231	0.00032	CcSEcCtD
Donepezil—Decreased appetite—Methotrexate—urinary bladder cancer	0.00023	0.000319	CcSEcCtD
Donepezil—Oedema—Doxorubicin—urinary bladder cancer	0.00023	0.000318	CcSEcCtD
Donepezil—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000229	0.000317	CcSEcCtD
Donepezil—Fatigue—Methotrexate—urinary bladder cancer	0.000229	0.000316	CcSEcCtD
Donepezil—Infection—Doxorubicin—urinary bladder cancer	0.000228	0.000316	CcSEcCtD
Donepezil—Pain—Methotrexate—urinary bladder cancer	0.000227	0.000314	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000226	0.000313	CcSEcCtD
Donepezil—Shock—Doxorubicin—urinary bladder cancer	0.000226	0.000313	CcSEcCtD
Donepezil—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000225	0.000312	CcSEcCtD
Donepezil—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000225	0.000311	CcSEcCtD
Donepezil—Insomnia—Epirubicin—urinary bladder cancer	0.000224	0.000311	CcSEcCtD
Donepezil—Paraesthesia—Epirubicin—urinary bladder cancer	0.000223	0.000308	CcSEcCtD
Donepezil—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000222	0.000307	CcSEcCtD
Donepezil—Dyspnoea—Epirubicin—urinary bladder cancer	0.000221	0.000306	CcSEcCtD
Donepezil—Somnolence—Epirubicin—urinary bladder cancer	0.000221	0.000305	CcSEcCtD
Donepezil—Anorexia—Doxorubicin—urinary bladder cancer	0.000219	0.000303	CcSEcCtD
Donepezil—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000218	0.000302	CcSEcCtD
Donepezil—Dyspepsia—Epirubicin—urinary bladder cancer	0.000218	0.000302	CcSEcCtD
Donepezil—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000217	0.0003	CcSEcCtD
Donepezil—Decreased appetite—Epirubicin—urinary bladder cancer	0.000216	0.000299	CcSEcCtD
Donepezil—Hypotension—Doxorubicin—urinary bladder cancer	0.000214	0.000297	CcSEcCtD
Donepezil—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000214	0.000296	CcSEcCtD
Donepezil—Fatigue—Epirubicin—urinary bladder cancer	0.000214	0.000296	CcSEcCtD
Donepezil—Constipation—Epirubicin—urinary bladder cancer	0.000212	0.000294	CcSEcCtD
Donepezil—Pain—Epirubicin—urinary bladder cancer	0.000212	0.000294	CcSEcCtD
Donepezil—Urticaria—Methotrexate—urinary bladder cancer	0.000211	0.000292	CcSEcCtD
Donepezil—Abdominal pain—Methotrexate—urinary bladder cancer	0.00021	0.00029	CcSEcCtD
Donepezil—Body temperature increased—Methotrexate—urinary bladder cancer	0.00021	0.00029	CcSEcCtD
Donepezil—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000209	0.00029	CcSEcCtD
Donepezil—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000208	0.00292	CbGpPWpGaD
Donepezil—Insomnia—Doxorubicin—urinary bladder cancer	0.000208	0.000287	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—HDAC4—urinary bladder cancer	0.000206	0.0029	CbGpPWpGaD
Donepezil—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000206	0.000285	CcSEcCtD
Donepezil—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000205	0.000283	CcSEcCtD
Donepezil—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000204	0.000283	CcSEcCtD
Donepezil—Somnolence—Doxorubicin—urinary bladder cancer	0.000204	0.000282	CcSEcCtD
Donepezil—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000203	0.000281	CcSEcCtD
Donepezil—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000202	0.00028	CcSEcCtD
Donepezil—Decreased appetite—Doxorubicin—urinary bladder cancer	0.0002	0.000276	CcSEcCtD
Donepezil—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000198	0.000274	CcSEcCtD
Donepezil—Fatigue—Doxorubicin—urinary bladder cancer	0.000198	0.000274	CcSEcCtD
Donepezil—Urticaria—Epirubicin—urinary bladder cancer	0.000197	0.000273	CcSEcCtD
Donepezil—Constipation—Doxorubicin—urinary bladder cancer	0.000196	0.000272	CcSEcCtD
Donepezil—Pain—Doxorubicin—urinary bladder cancer	0.000196	0.000272	CcSEcCtD
Donepezil—Body temperature increased—Epirubicin—urinary bladder cancer	0.000196	0.000271	CcSEcCtD
Donepezil—Abdominal pain—Epirubicin—urinary bladder cancer	0.000196	0.000271	CcSEcCtD
Donepezil—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000195	0.00027	CcSEcCtD
Donepezil—Asthenia—Methotrexate—urinary bladder cancer	0.00019	0.000263	CcSEcCtD
Donepezil—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000189	0.000262	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000188	0.00265	CbGpPWpGaD
Donepezil—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000188	0.00026	CcSEcCtD
Donepezil—Pruritus—Methotrexate—urinary bladder cancer	0.000188	0.00026	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000187	0.00263	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	0.000187	0.00262	CbGpPWpGaD
Donepezil—HRH3—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	0.000183	0.00257	CbGpPWpGaD
Donepezil—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000183	0.000253	CcSEcCtD
Donepezil—Urticaria—Doxorubicin—urinary bladder cancer	0.000182	0.000252	CcSEcCtD
Donepezil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000182	0.00255	CbGpPWpGaD
Donepezil—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000181	0.000251	CcSEcCtD
Donepezil—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000181	0.000251	CcSEcCtD
Donepezil—Diarrhoea—Methotrexate—urinary bladder cancer	0.000181	0.000251	CcSEcCtD
Donepezil—Asthenia—Epirubicin—urinary bladder cancer	0.000178	0.000246	CcSEcCtD
Donepezil—Pruritus—Epirubicin—urinary bladder cancer	0.000176	0.000243	CcSEcCtD
Donepezil—Dizziness—Methotrexate—urinary bladder cancer	0.000175	0.000243	CcSEcCtD
Donepezil—HRH3—Signaling Pathways—GLI1—urinary bladder cancer	0.000173	0.00243	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTZ1—urinary bladder cancer	0.000172	0.00242	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000172	0.00241	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	0.00017	0.00239	CbGpPWpGaD
Donepezil—Diarrhoea—Epirubicin—urinary bladder cancer	0.00017	0.000235	CcSEcCtD
Donepezil—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000169	0.000234	CcSEcCtD
Donepezil—Vomiting—Methotrexate—urinary bladder cancer	0.000169	0.000233	CcSEcCtD
Donepezil—Rash—Methotrexate—urinary bladder cancer	0.000167	0.000231	CcSEcCtD
Donepezil—Dermatitis—Methotrexate—urinary bladder cancer	0.000167	0.000231	CcSEcCtD
Donepezil—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000166	0.00234	CbGpPWpGaD
Donepezil—Headache—Methotrexate—urinary bladder cancer	0.000166	0.00023	CcSEcCtD
Donepezil—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	0.000165	0.00232	CbGpPWpGaD
Donepezil—Asthenia—Doxorubicin—urinary bladder cancer	0.000165	0.000228	CcSEcCtD
Donepezil—Dizziness—Epirubicin—urinary bladder cancer	0.000164	0.000227	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000164	0.0023	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTO2—urinary bladder cancer	0.000163	0.0023	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NAT1—urinary bladder cancer	0.000163	0.0023	CbGpPWpGaD
Donepezil—Pruritus—Doxorubicin—urinary bladder cancer	0.000162	0.000225	CcSEcCtD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000162	0.00227	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000161	0.00226	CbGpPWpGaD
Donepezil—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000159	0.00224	CbGpPWpGaD
Donepezil—Vomiting—Epirubicin—urinary bladder cancer	0.000158	0.000218	CcSEcCtD
Donepezil—Nausea—Methotrexate—urinary bladder cancer	0.000157	0.000218	CcSEcCtD
Donepezil—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000157	0.000217	CcSEcCtD
Donepezil—Rash—Epirubicin—urinary bladder cancer	0.000156	0.000217	CcSEcCtD
Donepezil—Dermatitis—Epirubicin—urinary bladder cancer	0.000156	0.000216	CcSEcCtD
Donepezil—Headache—Epirubicin—urinary bladder cancer	0.000155	0.000215	CcSEcCtD
Donepezil—Dizziness—Doxorubicin—urinary bladder cancer	0.000152	0.00021	CcSEcCtD
Donepezil—ACHE—Phospholipid metabolism—PTEN—urinary bladder cancer	0.000152	0.00213	CbGpPWpGaD
Donepezil—ACHE—Metabolism—UGT2B7—urinary bladder cancer	0.000149	0.0021	CbGpPWpGaD
Donepezil—Nausea—Epirubicin—urinary bladder cancer	0.000147	0.000204	CcSEcCtD
Donepezil—Vomiting—Doxorubicin—urinary bladder cancer	0.000146	0.000202	CcSEcCtD
Donepezil—Rash—Doxorubicin—urinary bladder cancer	0.000145	0.0002	CcSEcCtD
Donepezil—Dermatitis—Doxorubicin—urinary bladder cancer	0.000145	0.0002	CcSEcCtD
Donepezil—Headache—Doxorubicin—urinary bladder cancer	0.000144	0.000199	CcSEcCtD
Donepezil—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	0.00014	0.00197	CbGpPWpGaD
Donepezil—HRH3—GPCR ligand binding—CXCL8—urinary bladder cancer	0.000139	0.00196	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000138	0.00195	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000138	0.00194	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	0.000137	0.00193	CbGpPWpGaD
Donepezil—Nausea—Doxorubicin—urinary bladder cancer	0.000136	0.000189	CcSEcCtD
Donepezil—ACHE—Metabolism—CYP4B1—urinary bladder cancer	0.000135	0.00189	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	0.000134	0.00188	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	0.000133	0.00187	CbGpPWpGaD
Donepezil—ACHE—Metabolism—SLC19A1—urinary bladder cancer	0.000127	0.00179	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PRSS3—urinary bladder cancer	0.000124	0.00174	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000123	0.00173	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	0.000121	0.0017	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RBX1—urinary bladder cancer	0.000119	0.00167	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	0.000117	0.00165	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	0.000117	0.00164	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.000115	0.00162	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	0.000114	0.00161	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000114	0.0016	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000113	0.00159	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000112	0.00158	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	0.000111	0.00157	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TSC1—urinary bladder cancer	0.000111	0.00157	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000109	0.00153	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	0.000108	0.00152	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—JAG1—urinary bladder cancer	0.000106	0.00149	CbGpPWpGaD
Donepezil—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000106	0.00149	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	0.000106	0.00149	CbGpPWpGaD
Donepezil—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	0.000105	0.00148	CbGpPWpGaD
Donepezil—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000105	0.00147	CbGpPWpGaD
Donepezil—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000104	0.00146	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	9.92e-05	0.00139	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TYMP—urinary bladder cancer	9.9e-05	0.00139	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	9.71e-05	0.00136	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	9.5e-05	0.00134	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	9.5e-05	0.00133	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	9.07e-05	0.00127	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	9.05e-05	0.00127	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	8.97e-05	0.00126	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—RHOA—urinary bladder cancer	8.97e-05	0.00126	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NAT2—urinary bladder cancer	8.95e-05	0.00126	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—S100B—urinary bladder cancer	8.59e-05	0.00121	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—RHOA—urinary bladder cancer	8.14e-05	0.00114	CbGpPWpGaD
Donepezil—ACHE—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	7.97e-05	0.00112	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—CXCL8—urinary bladder cancer	7.87e-05	0.00111	CbGpPWpGaD
Donepezil—ACHE—Metabolism—RRM2—urinary bladder cancer	7.73e-05	0.00109	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—NCOR1—urinary bladder cancer	7.72e-05	0.00109	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	7.54e-05	0.00106	CbGpPWpGaD
Donepezil—HRH3—GPCR downstream signaling—IL2—urinary bladder cancer	7.52e-05	0.00106	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.44e-05	0.00105	CbGpPWpGaD
Donepezil—HTR2A—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	7.36e-05	0.00103	CbGpPWpGaD
Donepezil—ACHE—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.35e-05	0.00103	CbGpPWpGaD
Donepezil—ACHE—Metabolism—HPGDS—urinary bladder cancer	7.15e-05	0.00101	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ENO2—urinary bladder cancer	7.15e-05	0.00101	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—CXCL8—urinary bladder cancer	7.15e-05	0.001	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	7.11e-05	0.001	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	7.07e-05	0.000993	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	7.01e-05	0.000985	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTT1—urinary bladder cancer	6.94e-05	0.000975	CbGpPWpGaD
Donepezil—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	6.93e-05	0.000974	CbGpPWpGaD
Donepezil—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.84e-05	0.000961	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	6.83e-05	0.00096	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—IL2—urinary bladder cancer	6.83e-05	0.00096	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HDAC4—urinary bladder cancer	6.83e-05	0.00096	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TERT—urinary bladder cancer	6.81e-05	0.000957	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	6.7e-05	0.000942	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NAT1—urinary bladder cancer	6.7e-05	0.000942	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	6.64e-05	0.000933	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NAT1—urinary bladder cancer	6.64e-05	0.000933	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.53e-05	0.000918	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—FGFR3—urinary bladder cancer	6.25e-05	0.000878	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	6.13e-05	0.000861	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	6.07e-05	0.000854	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ESR1—urinary bladder cancer	6.07e-05	0.000853	CbGpPWpGaD
Donepezil—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—urinary bladder cancer	6.06e-05	0.000851	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—urinary bladder cancer	5.98e-05	0.00084	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—IGF1—urinary bladder cancer	5.83e-05	0.000819	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NQO1—urinary bladder cancer	5.77e-05	0.00081	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—GLI1—urinary bladder cancer	5.72e-05	0.000805	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—urinary bladder cancer	5.65e-05	0.000794	CbGpPWpGaD
Donepezil—ACHE—Neuronal System—HRAS—urinary bladder cancer	5.63e-05	0.000792	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	5.6e-05	0.000786	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	5.52e-05	0.000775	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.47e-05	0.000769	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CREBBP—urinary bladder cancer	5.32e-05	0.000747	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IGF1—urinary bladder cancer	5.25e-05	0.000738	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—EGFR—urinary bladder cancer	5.23e-05	0.000734	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	5.21e-05	0.000732	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.16e-05	0.000726	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	5.08e-05	0.000714	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.03e-05	0.000707	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—KRAS—urinary bladder cancer	4.94e-05	0.000694	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	4.88e-05	0.000686	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—RHOA—urinary bladder cancer	4.81e-05	0.000676	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTP1—urinary bladder cancer	4.81e-05	0.000676	CbGpPWpGaD
Donepezil—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—urinary bladder cancer	4.8e-05	0.000675	CbGpPWpGaD
Donepezil—ACHE—Metabolism of proteins—CXCL8—urinary bladder cancer	4.69e-05	0.000659	CbGpPWpGaD
Donepezil—ACHE—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	4.65e-05	0.000654	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	4.62e-05	0.000649	CbGpPWpGaD
Donepezil—HTR2A—GPCR ligand binding—CXCL8—urinary bladder cancer	4.61e-05	0.000648	CbGpPWpGaD
Donepezil—ACHE—Metabolism—TYMS—urinary bladder cancer	4.47e-05	0.000628	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—ERBB2—urinary bladder cancer	4.45e-05	0.000626	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GSTM1—urinary bladder cancer	4.42e-05	0.000621	CbGpPWpGaD
Donepezil—ACHE—Metabolism—NCOR1—urinary bladder cancer	4.42e-05	0.000621	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.38e-05	0.000616	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.38e-05	0.000616	CbGpPWpGaD
Donepezil—ACHE—Metabolism—GPX1—urinary bladder cancer	4.23e-05	0.000595	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CXCL8—urinary bladder cancer	4.22e-05	0.000594	CbGpPWpGaD
Donepezil—HRH3—Signaling by GPCR—HRAS—urinary bladder cancer	4.2e-05	0.00059	CbGpPWpGaD
Donepezil—ACHE—Metabolism—ERCC2—urinary bladder cancer	4.16e-05	0.000584	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.06e-05	0.00057	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—IL2—urinary bladder cancer	4.04e-05	0.000567	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.04e-05	0.000567	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.02e-05	0.000566	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.01e-05	0.000563	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CCND1—urinary bladder cancer	3.93e-05	0.000553	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RBX1—urinary bladder cancer	3.92e-05	0.000551	CbGpPWpGaD
Donepezil—ACHE—Metabolism—MTHFR—urinary bladder cancer	3.91e-05	0.000549	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.86e-05	0.000543	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MMP9—urinary bladder cancer	3.82e-05	0.000537	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—CDKN1A—urinary bladder cancer	3.81e-05	0.000535	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—PTEN—urinary bladder cancer	3.8e-05	0.000534	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TSC1—urinary bladder cancer	3.69e-05	0.000518	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NAT2—urinary bladder cancer	3.67e-05	0.000516	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.64e-05	0.000511	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EP300—urinary bladder cancer	3.62e-05	0.000509	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.61e-05	0.000507	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—SRC—urinary bladder cancer	3.52e-05	0.000495	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—JAG1—urinary bladder cancer	3.51e-05	0.000494	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.41e-05	0.000479	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.32e-05	0.000467	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.17e-05	0.000445	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PPARG—urinary bladder cancer	3.17e-05	0.000445	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—MYC—urinary bladder cancer	3.16e-05	0.000444	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.14e-05	0.000441	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—EGFR—urinary bladder cancer	3.09e-05	0.000434	CbGpPWpGaD
Donepezil—ACHE—Metabolism—CREBBP—urinary bladder cancer	3.04e-05	0.000428	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—RHOA—urinary bladder cancer	2.97e-05	0.000417	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.93e-05	0.000412	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.93e-05	0.000412	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—KRAS—urinary bladder cancer	2.92e-05	0.00041	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	2.91e-05	0.000409	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ENO2—urinary bladder cancer	2.91e-05	0.000409	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.89e-05	0.000406	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	2.85e-05	0.0004	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—S100B—urinary bladder cancer	2.84e-05	0.0004	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	2.82e-05	0.000397	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.78e-05	0.00039	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—RHOA—urinary bladder cancer	2.7e-05	0.000379	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.65e-05	0.000373	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—CXCL8—urinary bladder cancer	2.61e-05	0.000366	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—TP53—urinary bladder cancer	2.59e-05	0.000364	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—NCOR1—urinary bladder cancer	2.56e-05	0.000359	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTGS2—urinary bladder cancer	2.49e-05	0.00035	CbGpPWpGaD
Donepezil—HTR2A—GPCR downstream signaling—IL2—urinary bladder cancer	2.49e-05	0.00035	CbGpPWpGaD
Donepezil—HRH3—Signaling Pathways—HRAS—urinary bladder cancer	2.48e-05	0.000348	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.4e-05	0.000337	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—CXCL8—urinary bladder cancer	2.37e-05	0.000333	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.37e-05	0.000332	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.34e-05	0.00033	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.28e-05	0.00032	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—IL2—urinary bladder cancer	2.26e-05	0.000318	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TERT—urinary bladder cancer	2.25e-05	0.000317	CbGpPWpGaD
Donepezil—ACHE—Metabolism—PTEN—urinary bladder cancer	2.17e-05	0.000305	CbGpPWpGaD
Donepezil—ACHE—Metabolism—EP300—urinary bladder cancer	2.07e-05	0.000291	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.07e-05	0.000291	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—FGFR3—urinary bladder cancer	2.07e-05	0.000291	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ESR1—urinary bladder cancer	2.01e-05	0.000282	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.98e-05	0.000279	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.97e-05	0.000277	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.96e-05	0.000275	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.92e-05	0.00027	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.92e-05	0.00027	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.89e-05	0.000266	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.86e-05	0.000262	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.83e-05	0.000258	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.82e-05	0.000256	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.81e-05	0.000255	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.81e-05	0.000255	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.8e-05	0.000253	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.8e-05	0.000253	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CREBBP—urinary bladder cancer	1.76e-05	0.000247	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IGF1—urinary bladder cancer	1.74e-05	0.000244	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.74e-05	0.000244	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—EGFR—urinary bladder cancer	1.73e-05	0.000243	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.72e-05	0.000242	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.7e-05	0.00024	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.69e-05	0.000237	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—KRAS—urinary bladder cancer	1.63e-05	0.00023	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.6e-05	0.000225	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—RHOA—urinary bladder cancer	1.59e-05	0.000224	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.59e-05	0.000223	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.55e-05	0.000217	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—ERBB2—urinary bladder cancer	1.47e-05	0.000207	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CXCL8—urinary bladder cancer	1.4e-05	0.000196	CbGpPWpGaD
Donepezil—HTR2A—Signaling by GPCR—HRAS—urinary bladder cancer	1.39e-05	0.000195	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—IL2—urinary bladder cancer	1.34e-05	0.000188	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CCND1—urinary bladder cancer	1.3e-05	0.000183	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.3e-05	0.000183	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.29e-05	0.000181	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.29e-05	0.000181	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MMP9—urinary bladder cancer	1.26e-05	0.000178	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—CDKN1A—urinary bladder cancer	1.26e-05	0.000177	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—PTEN—urinary bladder cancer	1.26e-05	0.000177	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.25e-05	0.000175	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.24e-05	0.000174	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.2e-05	0.000169	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EP300—urinary bladder cancer	1.2e-05	0.000169	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.19e-05	0.000167	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.19e-05	0.000167	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—SRC—urinary bladder cancer	1.17e-05	0.000164	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.14e-05	0.00016	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.11e-05	0.000157	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.05e-05	0.000147	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—MYC—urinary bladder cancer	1.04e-05	0.000147	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.02e-05	0.000144	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—EGFR—urinary bladder cancer	1.02e-05	0.000144	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.01e-05	0.000142	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—KRAS—urinary bladder cancer	9.65e-06	0.000136	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—PTEN—urinary bladder cancer	8.91e-06	0.000125	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—PTEN—urinary bladder cancer	8.84e-06	0.000124	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—TP53—urinary bladder cancer	8.58e-06	0.000121	CbGpPWpGaD
Donepezil—CYP2D6—Metabolism—EP300—urinary bladder cancer	8.5e-06	0.000119	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PPARG—urinary bladder cancer	8.49e-06	0.000119	CbGpPWpGaD
Donepezil—CYP2C9—Metabolism—EP300—urinary bladder cancer	8.43e-06	0.000118	CbGpPWpGaD
Donepezil—HTR2A—Signaling Pathways—HRAS—urinary bladder cancer	8.21e-06	0.000115	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.16e-06	0.000115	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	6.68e-06	9.39e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—PTEN—urinary bladder cancer	5.83e-06	8.19e-05	CbGpPWpGaD
Donepezil—CYP3A4—Metabolism—EP300—urinary bladder cancer	5.56e-06	7.81e-05	CbGpPWpGaD
